Emerging Nanomedicines for Diabetes Mellitus Theranostics (Micro and Nano Technologies)

Elsevier
SKU:
9780323853965
|
ISBN13:
9780323853965
$222.98
(No reviews yet)
Condition:
New
Usually Ships in 24hrs
Current Stock:
Estimated Delivery by: | Fastest delivery by:
Adding to cart… The item has been added
Buy ebook
Diabetes has emerged as one of the most common diseases associated with lifestyle choices in the modern world, with significant mortality rates. Conventional treatment methods mainly involve insulin-based therapies. However, insulin therapy possesses several limitations such as weight gain and hypoglycaemia. Thus, advanced research in nanomedicine is targeting the development of new and improved diagnostics and treatment methods for diabetes. For example, there exist a plethora of literature supporting the development of novel nanomaterials as glucose sensors for rapid diabetes diagnosis as well as nanoformulations for controlled delivery of pharmaceutical ingredients to treat various types of diabetes. Emerging Nanomedicines for Diabetes Mellitus Theranostics provides readers with a information on the development of efficacious nanomedicines as potential theranostic agents for diabetes. The book also discusses the application of various novel nanomaterials and nanocomposites for targeted delivery of insulin, glucose sensing including nano-tattoos as glucose monitors, biosynthesized nanoparticles for diabetes treatment, and pre-clinical and clinical assays to evaluate the efficacy of nanomedicines for diabetes treatment. This is an important references source for materials scientists, pharmaceutical scientists and biomedical engineers who want to increase their understanding of how nanotechnology is being used to improve diabetes treatment. Explores the significance of nanomaterials and nanocomposites for controlled delivery of insulin and effective diagnosis of diabetes Assesses the efficacy of novel nano-tattoos as an emerging glucose monitoring system and the potential of biosynthesized nanoparticles as pharmaceutical ingredients for diabetes treatment Describes various pre-clinical and clinical assays to evaluate the toxicity of nanomedicines as well as methods to mitigate challenges associated with effective diabetes therapy via the use of nanorobots, nanoformulations, and smartphone-based technologies
  • | Author: Michael K. Danquah, Jaison Jeevanandam
  • | Publisher: Elsevier
  • | Publication Date: Apr 15, 2022
  • | Number of Pages: 280 pages
  • | Language: English
  • | Binding: Paperback
  • | ISBN-10: 032385396X
  • | ISBN-13: 9780323853965
Author:
Michael K. Danquah, Jaison Jeevanandam
Publisher:
Elsevier
Publication Date:
Apr 15, 2022
Number of pages:
280 pages
Language:
English
Binding:
Paperback
ISBN-10:
032385396X
ISBN-13:
9780323853965